It has been a good week for CSL Behring as it rolls out haemophilia B gene therapy Hemgenix, with positive reimbursement decisions in both the UK and Denmark.
Firefighters have been able to extinguish a fire that raged through an office building at the site of Novo Nordisk’s headquarters in Denmark, although it will not survive
The Novo Nordisk Foundation is funding the creation of a cell therapy development and manufacturing facility in Denmark with one of the largest investments in the sector i
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh